Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Nisar P. Malek, Prakash Ramachandran et al.|Journal of Hepatology|2023Cited by 92
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated ratsMo R. Ebrahimkhani, Ahmad Reza Dehpour, Samira Kiani et al.|Gut|2006Cited by 83
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approachPaul Brennan, Jonathan Fallowfield, Ahmed M. Elsharkawy et al.|Nature Reviews Gastroenterology & Hepatology|2023Cited by 70
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J. Kendall, Jonathan Fallowfield|Nature Medicine|2023Cited by 69
Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptorsDavid H. Wilson, Luke Boulter, Edward J. Jarman et al.|Nature Communications|2020Cited by 47